Biorelate

Biorelate is a biopharma-focused data curation platform that helps bioinformatics and drug discovery teams find new targets, validate and prioritise target lists, and understand mechanism of action as well as target-drug-disease relationships. Positioned as the provider of the most advanced data curation in biopharma, Biorelate enables researchers to move beyond surface-level literature searches and uncover deep causal, cause-and-effect insights drawn from multiple scientific sources.

The platform is designed to serve bioinformatics scientists, computational biologists, and drug discovery professionals within pharmaceutical and biotechnology organisations who need to extract actionable biological knowledge from the ever-growing body of published research.

Core Capabilities

• Advanced data curation that goes beyond standard PubMed searches to surface insights that would otherwise be missed through conventional knowledge reviews
• Identification and connection of causal relationships across multiple data sources, revealing cause-and-effect relationships not previously described in the literature
• Support for new target identification, enabling bioinformatics teams to discover novel drug targets from curated biological evidence
• Target validation and prioritisation, helping teams assess and rank candidate targets based on comprehensive, curated evidence
• Mechanism of action analysis, providing a deeper understanding of how targets, drugs, and diseases interrelate
• Mapping of target-drug-disease relationships to support informed decision-making throughout the drug discovery process

Why Advanced Data Curation Matters

• Relying solely on PubMed for knowledge reviews introduces significant limitations, leaving critical insights undiscovered
• Biorelate's approach connects together causal insights from multiple sources, building a richer and more complete picture of biological relationships
• The platform is designed to deliver measurable return on investment for biopharma organisations by accelerating and improving the quality of target identification and validation workflows
• Industry peers within biopharma have recognised the value of advanced data curation technology in supporting their research programmes

Resources and Engagement

• Biorelate offers detailed brochures covering the limitations of standard literature review approaches and the benefits of advanced curation technology
• Prospective customers can request a personalised demo to explore how the platform addresses their specific bioinformatics and drug discovery needs
• The company provides direct support and communication channels for organisations looking to learn more about integrating advanced data curation into their workflows

Biorelate is built for biopharma teams that need to extract the most complete and causally connected biological knowledge from scientific literature, enabling smarter, faster, and more confident decisions across the drug discovery pipeline.